Jefferies Group LLC Aspira Women'S Health Inc. Transaction History

Jefferies Group LLC

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$0.4 - $1.09 $4,073 - $11,100	-10,184 Closed	0 $0
Q1 2022 May 16, 2022	SELL	$0.88 - $1.81 $2,224 - $4,575	-2,528 Reduced 19.89%	10,184 $0
Q4 2021 Feb 14, 2022	BUY	$1.63 - $3.43 $20,720 - $43,602	12,712 New	12,712 $9,000

431K

Ticker AWH
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 124,296,000
Market Cap $123M
Description
Aspira Women's Health Inc., together with its subsidiaries, engages in developing and commercializing diagnostic tests for gynecologic disease in the United States. The company provides OVA1, OVERA, and OVA1plus to detect risk of ovarian malignancy in women with adnexal masses. It also offers ASPiRA GenetiX, a genetic test for the risk of gyneco...

Get notified when there are updates to the investment portfolio of Jefferies Group LLC, based on Form 13F filings with the SEC.

Stay updated on Jefferies Group LLC with notifications on news.